These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 12776806)
1. Cyclosporine bioavailability of two physically different oral formulations. Postolache P; Petrescu O; Dorneanu V; Zanini AC Eur Rev Med Pharmacol Sci; 2002; 6(6):127-31. PubMed ID: 12776806 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin A microemulsion: a randomized, open-label, two-period crossover study in healthy adult male Mexican volunteers. Piñeyro-López A; Piñeyro-Garza E; Torres-Alanís O; Reyes-Araiza R; Gómez-Silva M; Waksman N; E Salazar-Leal M; Luján-Rangel R Clin Ther; 2007 Sep; 29(9):2049-54. PubMed ID: 18035203 [TBL] [Abstract][Full Text] [Related]
3. Comparative bioavailability of the microemulsion formulation of cyclosporine (Neoral) with a generic dispersion formulation (Cicloral) in young healthy male volunteers. Kees F; Bucher M; Schweda F; Gschaidmeier H; Burhenne J; Mikus G; Faerber L Ther Drug Monit; 2006 Jun; 28(3):312-20. PubMed ID: 16778713 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two cyclosporine formulations in healthy volunteers: bioequivalence of the new Sang-35 formulation and Neoral. Schroeder TJ; Cho MJ; Pollack GM; Floc'h R; Moran HB; Levy R; Moore LW; Pouletty P J Clin Pharmacol; 1998 Sep; 38(9):807-14. PubMed ID: 9753208 [TBL] [Abstract][Full Text] [Related]
5. Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients. Curtis JJ; Barbeito R; Pirsch J; Lewis RM; Van Buren DH; Choudhury S Am J Kidney Dis; 1999 Nov; 34(5):869-74. PubMed ID: 10561143 [TBL] [Abstract][Full Text] [Related]
6. Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulation. Kovarik JM; Mueller EA; Johnston A; Hitzenberger G; Kutz K Pharmacotherapy; 1993; 13(6):613-7. PubMed ID: 8302687 [TBL] [Abstract][Full Text] [Related]
7. [Bioequivalence research of cyclosporin soft capsules]. Wu Y; Mao M; Wang L; Jiang X Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Apr; 29(2):311-4, 331. PubMed ID: 22616181 [TBL] [Abstract][Full Text] [Related]
8. A randomized, open-label, two-period, crossover bioavailability study of two oral formulations of tacrolimus in healthy Korean adults. Park K; Kim YS; Kwon KI; Park MS; Lee YJ; Kim KH Clin Ther; 2007 Jan; 29(1):154-62. PubMed ID: 17379055 [TBL] [Abstract][Full Text] [Related]
9. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728 [TBL] [Abstract][Full Text] [Related]
10. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs. Fischer JR; Harkin KR; Freeman LC Vet Ther; 2002; 3(4):465-73. PubMed ID: 12584684 [TBL] [Abstract][Full Text] [Related]
11. New cyclosporine microemulsion randomized, cross-over bioequivalence steady-state study in renal transplanted patients. Sinescu I; Lopes HV; Foschi D; Jen LH; Oliani C Eur Rev Med Pharmacol Sci; 1999; 3(1):11-8. PubMed ID: 10710824 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients. Perlík F; Masri MA; Rost M; Kamarád V Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):309-13. PubMed ID: 16601778 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers. Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838 [TBL] [Abstract][Full Text] [Related]
14. Cicloral versus neoral: a bioequivalence study in healthy volunteers on the influence of a fat-rich meal on the bioavailability of cicloral. Kees F; Mair G; Dittmar M; Bucher M Transplant Proc; 2004 Dec; 36(10):3234-8. PubMed ID: 15686736 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine bioequivalence study: quantification using fluorescence polarization immunoassay (FPIA) and radioimmunoassay (RIA). Mendes GD; de Oliveira CH; Sucupira M; Donato JL; Moreno RA; De Nucci G Int J Clin Pharmacol Ther; 2004 Feb; 42(2):125-32. PubMed ID: 15180174 [TBL] [Abstract][Full Text] [Related]
16. Biowaiver extension potential and IVIVC for BCS Class II drugs by formulation design: Case study for cyclosporine self-microemulsifying formulation. Yang SG Arch Pharm Res; 2010 Nov; 33(11):1835-42. PubMed ID: 21116787 [TBL] [Abstract][Full Text] [Related]
17. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs. Steffan J; Strehlau G; Maurer M; Rohlfs A J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852 [TBL] [Abstract][Full Text] [Related]
18. Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation. Yang SG; Kim DD; Chung SJ; Shim CK Int J Clin Pharmacol Ther; 2006 May; 44(5):233-9. PubMed ID: 16724578 [TBL] [Abstract][Full Text] [Related]
19. Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Grenier J; Fradette C; Morelli G; Merritt GJ; Vranderick M; Ducharme MP Clin Pharmacol Ther; 2006 Mar; 79(3):255-62. PubMed ID: 16513449 [TBL] [Abstract][Full Text] [Related]
20. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]